NCT00604253View on ClinicalTrials.gov

Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone

PHASE3CompletedINTERVENTIONAL

Enrollment

362

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY